Medical Developments International Limited (ASX:MVP)

$4.88

right-arrow Created with Sketch. -0.2 (-3.94%)
MCAP $347.8M
Last trade 16.10pm 26/11/2021 20mins delayed

Latest Announcements

26/11/2021MVPMedical Developments International Limited
26/11/2021MVPMedical Developments International Limited
138
MCap
25/11/2021MVPMedical Developments International Limited
05/11/2021MVPMedical Developments International Limited
29/10/2021MVPMedical Developments International Limited
29/10/2021MVPMedical Developments International Limited
28/10/2021 Price SensitivePSMVPMedical Developments International Limited
27/09/2021MVPMedical Developments International Limited

Company Overview

Medical Developments International Limited is an Australia-based healthcare company. The Company is focused on manufacturing and distributing pharmaceutical drugs, and medical and veterinary equipment. The Company operates through three segments: Pharmaceuticals, Medical Devices and Veterinary Products. The Pharmaceuticals segment is engaged in the sale of Penthrox primarily within Australia, New Zealand, Europe and the United Kingdom, and some sales in the Middle East, Asia and South Africa. The Medical Devices segment is engaged in the sale of medical devices, particularly the Space Chamber and Breath-Alert PeakFlow meters, primarily within Australia, the United Kingdom/Europe, North America, and some sales in Asia and New Zealand. The Veterinary Products segment is engaged in the sale of veterinary products within Australia, Europe, and Asia.

MVP in the news

Medical Developments International (MVP) shares dropped into the red after the company…
Medical Developments (MVP) expects a non-cash charge of between $7.5 and $8.5…
Medical Developments International (MVP) has entered a trading halt regarding an upcoming…
Medical Developments International (MVP) is preparing to take back the distribution rights…

Search Previous Announcements